Organization | Novexel Inc

Novexel Inc Report issue

Contributed to NME For profit Phase 2

Founded: Romainville France (2004)

Status: Acquired by AstraZeneca (2009)

Organization Overview

First Clinical Trial

2007

NCT00653172

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (9)

avibactam (Avycaz) (2 trials)

ceftazidime (fortaz) (2 trials)

cilastatin (primaxin) (1 trial)

flopristin (2 trials)

imipenem (primaxin) (1 trial)

linezolid (zyvox) (1 trial)

linopristin (2 trials)

meropenem (merrem) (1 trial)

metronidazole (flagyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Communicable Diseases (Phase 2)

Infections (Phase 2)

Intraabdominal Infections (Phase 2)

Pneumonia (Phase 2)

Skin Diseases, Bacterial (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 9